We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacterial Pneumonia Responds Best to an Antibiotic and Steroid Cocktail

By LabMedica International staff writers
Posted on 21 Oct 2008
Researchers working with a mouse model of bacterial pneumonia have found that treatment with a combination of antibiotic and corticosteroid was more effective than antibiotic treatment alone in curing the disease.

Mycoplasma pneumoniae causes a relatively benign type of respiratory disease that accounts for 20 to 30% of all community-acquired pneumonia cases. More...
Traditionally, infections with M. pneumoniae are treated with antibiotics. However, while this treatment eliminates the causative agent of the respiratory disease, it does not aid in reducing inflammation and swelling in the lungs.

In a study published in the October 15, 2008, issue of the Journal of Infectious Diseases, investigators at the University of Texas Southwestern Medical Center (Dallas, USA) combined traditional antibiotic treatment (in this study clarithromycin) to kill the pathogenic bacteria with corticosteroid treatment to reduce inflammation.

Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex. They are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. The steroid used in this study was dexamethasone.

Mice were infected with M. pneumoniae and then separated into separate treatment groups. Different groups were treated with clarithromycin, dexamethasone, combined clarithromycin/dexamethasone, or a placebo daily. The mice were evaluated at the start of the therapy and after one, three, and six days of treatment.

Results showed that while antibiotic therapy with clarithromycin had the greatest effect on reducing concentrations of M. pneumoniae, combination antibiotic/steroid therapy had the greatest effect on decreasing levels of cytokines and chemokines as well as reducing lung inflammation.

"It turns out that the group that got both the antibiotic and the steroids did the best,” said senior author Dr. Robert Hardy, associate professor of internal medicine and pediatrics at the University of Texas Southwestern Medical Center. "The inflammation in their lungs got significantly better. Some people might think that if you give steroids, it would counteract the effect of the antibiotic, but it turns out you need the antibiotic to kill the bug and the steroid to make the inflammation in the lung from the infection get better. The steroids do not kill the bugs, but they do help restore health.”

Related Links:
University of Texas Southwestern Medical Center



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.